Remitogen
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Multiple myeloma (MM) is the second most commonly diagnosed hematologic malignancy after non-Hodgkin lymphoma and remains…
Dr. Nabhan and his coauthors have written a comprehensive review of the use of monoclonal antibodies in the treatment of chronic…
The humanized monoclonal antibody Hu1D10 (Remitogen™3;, Protein Design Labs, Fremont, CA) recognizes a polymorphic determinant of…
Summary. Antibody‐based approaches have become a novel treatment modality for lymphoma patients. Humanized 1D10 (Hu1D10…